← CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.7b |
$1.9b
+10.48%
|
$2.3b
+21.99%
|
$2.6b
+15.67%
|
$2.9b
+11.55%
|
$3.5b
+21.08%
|
$4.0b
+12.31%
|
$4.1b
+3.86%
|
$4.0b
-1.92%
|
$4.0b
-0.85%
|
$4.0b
-0.41%
|
|
| Cost of Goods and Services Sold | $277.0m |
$289.7m
+4.56%
|
$1.5b
+414.68%
|
$1.8b
+17.55%
|
$2.0b
+11.97%
|
$2.3b
+18.76%
|
$2.7b
+14.14%
|
$2.8b
+3.92%
|
$3.1b
+11.12%
|
$3.2b
+5.71%
|
$2.7b
-17.08%
|
|
| Gross Profit (Calculated) (derived) | $1.4b |
$1.6b
+11.64%
|
$775.2m
-50.56%
|
$868.8m
+12.07%
|
$961.7m
+10.69%
|
$1.2b
+25.80%
|
$1.3b
+8.79%
|
$1.4b
+3.73%
|
$978.4m
-28.33%
|
$768.2m
-21.48%
|
— | |
| Selling, General and Administrative Expense | $367.5m | $373.4m | $443.9m | $517.6m | $528.9m | $619.9m | $665.1m | $747.9m | $751.0m | $743.1m | $762.0m | |
| Amortization of Intangible Assets | $41.7m | $41.4m | $64.8m | $89.5m | $111.9m | $124.9m | $146.6m | $137.4m | $138.5m | $179.1m | — | |
| Restructuring and Related Cost, Incurred Cost | — | $4.3m | $8.7m | $12.7m | $9.3m | $5.7m | — | $11.5m | — | — | — | |
| Operating Income (Loss) | $237.4m |
$287.5m
+21.09%
|
$331.4m
+15.26%
|
$351.2m
+5.97%
|
$432.7m
+23.23%
|
$589.9m
+36.31%
|
$651.0m
+10.36%
|
$617.3m
-5.18%
|
$227.3m
-63.17%
|
$25.2m
-88.93%
|
$466.1m
+1752.47%
|
|
| Investment Income, Interest | $1.3m | $690k | $812k | $1.5m | $834k | $652k | $780k | $5.2m | $8.6m | $4.9m | — | |
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement | — | $0 | $0 | — | — | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | $11.9m | $38.5m | $13.3m | $12.3m | $100.0m | ($35.9m) | $30.5m | $95.5m | ($16.5m) | ($22.6m) | — | |
| Interest Expense (non-operating) | $27.7m | $29.8m | $63.8m | $60.9m | $86.4m | $73.9m | $59.3m | $136.7m | $126.3m | $107.0m | $106.3m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $59.3m | $123.9m | $95.1m | $108.3m | $226.9m | $129.6m | $280.1m | $185.7m | ($290.3m) | ($290.6m) | ($183.7m) | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $222.9m | $297.0m | $281.7m | $304.1m | $447.1m | $480.7m | $623.0m | $581.3m | $93.1m | ($99.5m) | ($183.7m) | |
| Current Income Tax Expense (Benefit) | $63.7m | $143.4m | $64.8m | $71.5m | $80.2m | $102.2m | $163.5m | $152.3m | $135.0m | $118.0m | $52.6m | |
| Income Tax Expense (Benefit) | $66.8m | $171.4m | $54.5m | $50.0m | $81.8m | $81.9m | $130.4m | $100.9m | $67.8m | $42.7m | $52.6m | |
| Net Income (Loss) Attributable to Parent | $154.8m |
$123.4m
-20.30%
|
$226.4m
+83.51%
|
$252.0m
+11.33%
|
$364.3m
+44.55%
|
$391.0m
+7.32%
|
$486.2m
+24.36%
|
$474.6m
-2.39%
|
$22.2m
-95.32%
|
($144.3m)
-750.08%
|
($238.5m)
-65.21%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $1.6m | $2.1m | $2.4m | $2.0m | $1.0m | $7.9m | $6.4m | $5.7m | $3.1m | $2.2m | ($238.5m) | |
| Earnings Per Share, Basic | $3.29 | $2.60 | $4.72 | $5.17 | $7.35 | $7.77 | $9.57 | $9.27 | $0.20 | ($2.91) | ($4.81) | |
| Earnings Per Share, Diluted | $3.23 | $2.54 | $4.62 | $5.07 | $7.20 | $7.60 | $9.48 | $9.22 | $0.20 | ($2.91) | ($4.81) | |
| Income (Loss) from Continuing Operations, Per Basic Share | $3 | $3 | $5 | $5 | $7 | $8 | $10 | $9 | $0 | ($3) | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $3 | $3 | $5 | $5 | $7 | $8 | $10 | $9 | $0 | ($3) | — | |
| Weighted Average Number of Shares Outstanding, Basic | 47.0m | 47.5m | 47.9m | 48.7m | 49.5m | 50.3m | 50.8m | 51.2m | 51.4m | 49.6m | 48.9m | |
| Weighted Average Number of Shares Outstanding, Diluted | 48.0m | 48.6m | 49.0m | 49.7m | 50.6m | 51.4m | 51.3m | 51.5m | 51.6m | 49.6m | 48.9m | |
| Additional Financial Items | ||||||||||||
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | — | — | — | — | — | — | $17.4m | — | |
| Goodwill, Impairment Loss | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $215.0m | $165.0m | $376.0m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $156.1m | $125.6m | $227.2m | $254.1m | $365.3m | $7.9m | $6.4m | $5.7m | $3.1m | $2.2m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $280k | ($137k) | $1.5m | $0 | $0 | — | — | — | $3.1m | $2.2m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.